Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies.
Saved in:
| Title: | Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies. |
|---|---|
| Authors: | Clements JD; Clinical Pharmacology, Modeling & Simulation, Amgen Inc., Thousand Oaks, CA, USA., Zhu M; Clinical Pharmacology, Modeling & Simulation, Amgen Inc., Thousand Oaks, CA, USA.; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Kuchimanchi M; Clinical Pharmacology, Modeling & Simulation, Amgen Inc., Thousand Oaks, CA, USA.; Biogen, Cambridge, MA, USA., Terminello B; Clinical Pharmacology, Modeling & Simulation, Amgen Inc., Thousand Oaks, CA, USA., Doshi S; Clinical Pharmacology, Modeling & Simulation, Amgen Inc., Thousand Oaks, CA, USA. sdoshi@amgen.com. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2020 Apr; Vol. 59 (4), pp. 463-474. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1926 |
|---|---|
| DOI: | 10.1007/s40262-019-00823-8 |
